Relative Abuse Liability of Different Benzodiazepines in: Drug Abusers

  title={Relative Abuse Liability of Different Benzodiazepines in: Drug Abusers},
  author={Roland R. Griffiths and Barbara Wolf},
  journal={Journal of Clinical Psychopharmacology},
  • R. Griffiths, B. Wolf
  • Published 1 August 1990
  • Psychology, Medicine
  • Journal of Clinical Psychopharmacology
There is a convergence of data from various sources suggesting that there are meaningful differences among the benzodiazepines with respect to their attractiveness as drugs of abuse for drug abusers. Laboratory studies of subjective and reinforcing effects in drug abusers, interviews with drug abusers, clinical judgment of medical professionals, and epidemiological studies all indicate that diazepam, in particular, has a greater abuse liability than many of the other benzodiazepines. Some of… 

A postmarketing study of relative abuse liability of hypnotic sedative drugs.

This pilot study suggests that postmarketing information on hypnotic drug use obtained from drug addicts entering treatment produces data consistent with other measures of abuse liability, and suggests that the risk of misuse of newer non-benzodiazepine hypnotics may be less than that of benzodiazepines, and similar to that of sedating antidepressants.

Safety and Abuse Liability of Oxazepam: Is This Benzodiazepine Drug Underutilized?

  • R. Howland
  • Medicine, Psychology
    Journal of psychosocial nursing and mental health services
  • 2016
Compared to other benzodiazepine drugs, oxazepam has a favorable safety and abuse liability profile, which may be related to its pharmacology.

Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse

A current review of various problems that have been identified with the long-term use and the recreational abuse of benzodiazepines, including memory impairment, risk of accidents, falls and hip fractures in the elderly, a withdrawal syndrome, brain damage, overuse inThe elderly, over use by chronic pain patients, overused by alcoholics and recreational abuse among alcoholic and polydrug abusers are provided.

Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond


Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system depressants, yet much remains unknown about BZD abuse.

Is quetiapine a drug of abuse? Reexamining the issue of addiction

To better understand this surging pattern of abuse and diversion of quetiapine in forensic population and in individuals with histories of substance abuse the available body of evidence was critically examined.

Abuse liability of flunitrazepam.

Experimental studies of animals and normal human subjects indicate that, although flunitrazepam has high efficacy and is very potent, it is pharmacologically similar to most other benzodiazepines.